ADAR1 Capital Management »

Abbott Laboratories shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Abbott Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Abbott Laboratories held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbott Laboratories by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $159k 1.4k 113.66

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Abbott Laboratories

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital Research and Management Company - Division 3
Capital Research Global Investors
Morgan Stanley
Geode Capital Management
Jpmorgan Chase & Co
Northern Trust
Wells Fargo & Company
Polen Capital Management
State Farm Mutual Automobile Insurance Company
Bank of New York Mellon
Massachusetts Financial Services

View all funds holding Abbott Laboratories